JUST IN
You are here » Home » Company » Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd.

BSE: 500660 Sector: Health care
NSE: GLAXO ISIN Code: INE159A01016
BSE 00:00 | 20 Feb 1344.85 3.15
(0.23%)
OPEN

1342.00

 HIGH

1358.00

 LOW

1338.55
NSE 00:00 | 20 Feb 1344.65 3.30
(0.25%)
OPEN

1341.80

 HIGH

1358.00

 LOW

1336.00
Add to Watchlist  |   Add to Portfolio
OPEN 1342.00
PREVIOUS CLOSE 1341.70
VOLUME 2300
52-Week high 1745.00
52-Week low 1131.05
P/E 55.57
Mkt Cap.(Rs cr) 22,783
Buy Price 1330.00
Buy Qty 10.00
Sell Price 1344.85
Sell Qty 4.00
OPEN 1342.00
CLOSE 1341.70
VOLUME 2300
52-Week high 1745.00
52-Week low 1131.05
P/E 55.57
Mkt Cap.(Rs cr) 22,783
Buy Price 1330.00
Buy Qty 10.00
Sell Price 1344.85
Sell Qty 4.00

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc UK one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives dermatology g...> More

Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   22,783
EPS - TTM () [*S] 24.20
P/E Ratio (X) [*S] 55.57
Face Value ()   10
Latest Dividend (%)   200.00
Latest Dividend Date 11 Jul 2019
Dividend Yield (%) 1.49
Book Value / Share () [*S] 138.61
P/B Ratio () [*S] 9.70
[*C] Consolidated     [*S] Standalone    

News

Announcement

Glaxosmithkline Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 778.59 825.35 -5.67
Other Income 16.5 45.42 -63.67
Total Income 795.09 870.77 -8.69
Total Expenses 1408.1 688.2 104.61
Operating Profit -613.01 182.57 -435.77
Net Profit -661.16 113.67 -681.65
Equity Capital 169.41 169.41 -
> More on Glaxosmithkline Pharmaceuticals Ltd Financials Results

Glaxosmithkline Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alkem Lab 2657.75 1.39 31773.40
Lupin 699.20 -1.36 31670.26
Cadila Health. 279.30 1.10 28591.94
Glaxosmi. Pharma 1344.85 0.23 22783.10
Pfizer 4182.85 -0.89 19136.54
Ipca Labs. 1456.15 3.43 18398.46
Sanofi India 7322.90 2.05 16864.64
> More on Glaxosmithkline Pharmaceuticals Ltd Peer Group

Glaxosmithkline Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 7.05
FIIs 0.51
Insurance 0.00
Mutual Funds 3.96
Indian Public 10.97
Custodians 0.00
Other 2.50
> More on Glaxosmithkline Pharmaceuticals Ltd Share Holding Pattern

Glaxosmithkline Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
21/05 Centrum Broking Sell 1278 PDF IconDetails
> More on Glaxosmithkline Pharmaceuticals Ltd Research Reports

Glaxosmithkline Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 0.07% 0.06% -0.70% -0.77%
1 Month -17.52% -17.52% -0.86% -1.18%
3 Month -18.95% -19.00% 1.28% 0.68%
6 Month 11.36% 11.39% 10.29% 9.66%
1 Year 0.69% 0.65% 15.14% 12.53%
3 Year 0.32% 0.38% 43.64% 36.06%

Glaxosmithkline Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 1338.55
1358.00
Week Low/High 1301.90
1363.00
Month Low/High 1280.00
1745.00
YEAR Low/High 1131.05
1745.00
All TIME Low/High 12.88
1925.00

Browse STOCK Companies

Quick Links for Glaxosmithkline Pharmaceuticals: